Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,606.49
(
-0.27%
)
US TECH 100
23,564.00
(
-0.66%
)
Dow Jones
46,021.43
(
-0.44%
)
Brent Oil
106.27
(
1.76%
)
Bitcoin
70,729.00
(
1.19%
)
News Focus
News Focus
Post# of 257262
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

AlpineBV_Miller

Send PM Follow Ignore
Followers 54
Posts 1150
Boards Moderated 0
Alias Born 11/12/2005

AlpineBV_Miller

Re: jq1234 post# 117024

Friday, 03/25/2011 3:30:27 PM

Friday, March 25, 2011 3:30:27 PM

Post# of 257262
Provenge will be the cheapest (or in the bottom couple) cancer biologics approved this decade.

(ok, for the AR folks out there, 2010 forward since technically the decade started 2011)

Unless otherwise indicated, this is the personal viewpoint of David
Miller and not necessarily that of Biotech Stock Research, LLC.
We're on Twitter at BiotechStockRsr

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now